TGFβ2 Induces the Soluble Isoform of CTLA-4 - Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant Melanoma.
Khanolkar RC, Zhang C, Al-Fatyan F, Lawson L, Depasquale I, Meredith FM, Muller F, Nicolson M, Dahal LN, Abu-Eid R, Rajpara S, Barker RN, Ormerod AD, Ward FJ.
Khanolkar RC, et al. Among authors: dahal ln.
Front Immunol. 2022 Jan 5;12:763877. doi: 10.3389/fimmu.2021.763877. eCollection 2021.
Front Immunol. 2022.
PMID: 35069536
Free PMC article.